Javascript must be enabled to continue!
Distinct different expression of Th17 and Th9 cells in coxsackie virus B3-induced mice viral myocarditis
View through CrossRef
Abstract
Background
Recently, a new subset of CD4+T helper(Th) cell that predominantly secret cytokine interleukin-9(IL-9) is identified, termed Th9 cell. It has been reported to participate in tissue inflammation and autoimmune responses, and induce disease which differed from Th17 cells. Th17 cells have been shown to play a critical role in viral myocarditis (VMC), but whether Th9 cells are involved in the pathogenesis of VMC remains unclear.
Results
BALB/c mice were intraperitoneally (i.p) injected with coxsackie virus B3(CVB3) for establishing VMC models. Control mice were treated with phosphate-buffered saline i.p. On day 0,7,14,21,28,35,42 after injection, myocardial histopathological changes were evaluated by hematoxylin-eosin staining. Splenic Th17 and Th9 cells subsets were analyzed by flow cytometry. And cardiac IL-17, IL-9 mRNA were measured by semi-quantitative reverse transcription-PCR and nested PCR, respectively. Results showed the levels of Th17 cells and IL-17 mRNA obviously increased in VMC mice on 7 day after infection, peaked on day 28, and highly persisted to at least day 42 (p < 0.05). While the frequencies of Th9 cells and IL-9 mRNA showed no significant difference between VMC and control group throughout the course of the experiment(p > 0.05).
Conclusions
It was differentiated Th17 but not Th9 cells significantly elevated in the development of CVB3-induced VMC. The microenvironment of VMC seemed to contribute to the differentiation and proliferation of Th17 rather than Th9 cells. Our preliminary data implied Th9 cells could not protect against VMC nor promote the disease.
Springer Science and Business Media LLC
Title: Distinct different expression of Th17 and Th9 cells in coxsackie virus B3-induced mice viral myocarditis
Description:
Abstract
Background
Recently, a new subset of CD4+T helper(Th) cell that predominantly secret cytokine interleukin-9(IL-9) is identified, termed Th9 cell.
It has been reported to participate in tissue inflammation and autoimmune responses, and induce disease which differed from Th17 cells.
Th17 cells have been shown to play a critical role in viral myocarditis (VMC), but whether Th9 cells are involved in the pathogenesis of VMC remains unclear.
Results
BALB/c mice were intraperitoneally (i.
p) injected with coxsackie virus B3(CVB3) for establishing VMC models.
Control mice were treated with phosphate-buffered saline i.
p.
On day 0,7,14,21,28,35,42 after injection, myocardial histopathological changes were evaluated by hematoxylin-eosin staining.
Splenic Th17 and Th9 cells subsets were analyzed by flow cytometry.
And cardiac IL-17, IL-9 mRNA were measured by semi-quantitative reverse transcription-PCR and nested PCR, respectively.
Results showed the levels of Th17 cells and IL-17 mRNA obviously increased in VMC mice on 7 day after infection, peaked on day 28, and highly persisted to at least day 42 (p < 0.
05).
While the frequencies of Th9 cells and IL-9 mRNA showed no significant difference between VMC and control group throughout the course of the experiment(p > 0.
05).
Conclusions
It was differentiated Th17 but not Th9 cells significantly elevated in the development of CVB3-induced VMC.
The microenvironment of VMC seemed to contribute to the differentiation and proliferation of Th17 rather than Th9 cells.
Our preliminary data implied Th9 cells could not protect against VMC nor promote the disease.
Related Results
Bcl-3 suppresses Th9 differentiation by regulating glutamine utilization
Bcl-3 suppresses Th9 differentiation by regulating glutamine utilization
Summary
Bcl-3 is an atypical member of the IκB protein family that plays important and diverse roles in both innate and adaptive immunity, includ...
Integrated Bioinformatics analysis and Metabolomic Responses in finding novel therapeutic approach to treat viral myocarditis
Integrated Bioinformatics analysis and Metabolomic Responses in finding novel therapeutic approach to treat viral myocarditis
Abstract
Background
Myocarditis is one of the most common health problems in young people. Despite imaging...
Endothelin-A Receptor Activation Stimulates Th17 Cell Differentiation
Endothelin-A Receptor Activation Stimulates Th17 Cell Differentiation
Th17 cells are a major contributor to many pro-inflammatory disease conditions. Endothelin 1 (ET-1) through the ETA receptor promotes inflammation, however its role in T cell diffe...
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
<p>Supplementary Methods, Supplementary Figures S1-S15 Fig. S1. Purification and binding specificity of MV-encoded BiTEs. (A) Purification of MV-expressed BiTEs. Vero cells w...
Double‐negative T cells regulate the progression of liver fibrosis through Th9 cells differentiation
Double‐negative T cells regulate the progression of liver fibrosis through Th9 cells differentiation
AbstractOur previous study found that double negative T cells (DNTs) could promote the NLRP3 activation through high expression of TNF‐α, thereby leading to hepatic fibrosis progre...
Bregs Correction of Th17/Tregs Imbalance Regulates Systemic Lupus Erythematosus Complicated with Atherosclerosis
Bregs Correction of Th17/Tregs Imbalance Regulates Systemic Lupus Erythematosus Complicated with Atherosclerosis
Abstract
Objectives
To investigate the dynamics of Bregs in the pathogenesis of systemic lupus erythematosus (SLE) complicating atherosclerosis in mice and their relations...
Abstract 1760: Role of Batf-dependant Th17 immune response in PTEN-null mouse model
Abstract 1760: Role of Batf-dependant Th17 immune response in PTEN-null mouse model
Abstract
Basic leucine zipper transcription factor ATF-like (BATF) belongs to the activator protein 1 (AP-1) family of transcription factors and has been shown to be...
Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges
Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges
Abstract
Background
Immune checkpoint inhibitors (ICIs), which are increasingly used in cancer pharmacotherapy, can induce myoca...

